Lipids in Alzheimer’s disease and their potential for therapy-Reference-Cited by-同舟云学术

Lipids in Alzheimer’s disease and their potential for therapy

Published:2012-02-01 Issue:1 Volume:7 Page:65-78
ISSN:1758-4299
Container-title:Clinical Lipidology
language:en
Short-container-title:Clinical Lipidology

Author:

Lütjohann Dieter¹,Meichsner Sabrina¹,Pettersson Hanna¹

Affiliation:

1. Laboratory for Special Lipid Diagnostics/Center Internal Medicine/ UG 68, Institute of Clinical Chemistry & Clinical Pharmacology, University Clinics of Bonn, Sigmund-Freud-Str. 25 D-53127 Bonn, Germany

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.2217/clp.11.74

Reference125 articles.

1. Holtzman DM, Morris JC, Goate AM. Alzheimer’s disease: the challenge of the second century. Sci. Transl. Med. 3(77), 77sr71 (2011).

2. Di Paolo G, Kim TW. Linking lipids to Alzheimer’s disease: cholesterol and beyond. Nat. Rev. Neurosci. 12(5), 284–296 (2011).

3. Mielke MM, Lyketsos CG. Lipids and the pathogenesis of Alzheimer’s disease: is there a link? Int. Rev. Psychiatry 18(2), 173–186 (2006).

4. Alzheimer A. Über einen eigenartigen schweren Erkrankungsprozeß der Hirnrinde. Neurologisches Zentralblatt 23, 1129–1136 (1906).

5. Walter J. Gamma-secretase, apolipoprotein E and cellular cholesterol metabolism. Curr. Alzheimer Res. doi:BSP/CAR/E-Pub/00047 (2011) (Epub ahead of print).

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Silico Interactions of Natural and Synthetic Compounds with Key Proteins Involved in Alzheimer’s Disease: Prospects for Designing New Therapeutics Compound;Neurotoxicity Research;2023-04-22

2. Cholesterol and Dementia: A Possible Therapeutic Approach;Current Thoughts on Dementia;2022

3. Serum Metabolites Differentiate Amnestic Mild Cognitive Impairment From Healthy Controls and Predict Early Alzheimer's Disease via Untargeted Lipidomics Analysis;Frontiers in Neurology;2021-08-02

4. ACAT1 as a Therapeutic Target and its Genetic Relationship with Alzheimer's Disease;Current Alzheimer Research;2019-10-11

5. Oxysterols as a biomarker in diseases;Clinica Chimica Acta;2019-04